Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial.

Norio OhmagariHiroshi YotsuyanagiYohei DoiMasaya YamatoTakumi ImamuraHiroki SakaguchiHideki YamanakaRyosuke ImaokaAkimasa FukushiGenki IchihashiTakao SanakiYuko TsugeTakeki UeharaHiroshi Mukae

Published in: Influenza and other respiratory viruses (2024)

Japan Registry of Clinical Trials identifier: jRCT2031210350.

Keyphrases

clinical trial
double blind
coronavirus disease
placebo controlled
sars cov
phase ii
phase iii
open label
study protocol
respiratory syndrome coronavirus